Multidrug-resistant Burkholderia pseudomallei pneumonia misdiagnosed as tuberculosis: A case report. [PDF]
Zhou Q, Gao Y, Liang Y.
europepmc +1 more source
[Distribution of the Pathogens Isolated from 6428 Tumor Patients in 2019-2023 and the Relevant Drug Resistance Surveillance Report]. [PDF]
Tang Q +5 more
europepmc +1 more source
[Application of Nano-drug Delivery Technology in Overcoming Drug Resistance in Lung Cancer]. [PDF]
Lu Y, Wang C, Liu B.
europepmc +1 more source
[Chinese expert consensus on the diagnosis and treatment strategies for refractory/resistant cytomegalovirus infection in immunocompromised populations (2025)]. [PDF]
Infectiology Group +6 more
europepmc +1 more source
[Literature review and experience in treatment of multidrug-resistant bacterial infection in operative area after cochlear implantation]. [PDF]
Luo W, Wu P, Lai Y, Cui Y, Huang H.
europepmc +1 more source
[Case Report: Histological Transformation to Atypical Carcinoid in RET Fusion-positive NSCLC Following Immune Therapy Resistance]. [PDF]
Zhang Y +4 more
europepmc +1 more source
[METTL3-mediated m<sup>6</sup>A modification promotes FOXO3 expression and anthracycline resistance in acute myeloid leukemia cells through autophagy regulation]. [PDF]
Zhang X +5 more
europepmc +1 more source
[Layered double hydroxide-loaded si-NEAT1 regulates paclitaxel resistance and tumor-associated macrophage polarization in breast cancer by targeting miR-133b/PD-L1]. [PDF]
Zhang Z +8 more
europepmc +1 more source
Future of PARP inhibitors in cancer treatment: overcoming resistance and enhancing efficacy with combination therapies. [PDF]
Shoaib M +6 more
europepmc +1 more source
[High expression of DTX2 promotes proliferation, invasion and epithelial-mesenchymal transition of oxaliplatin-resistant colorectal cancer cells]. [PDF]
Ma Z, Liu F, Zhao X, Zhang X.
europepmc +1 more source

